terazosin has been researched along with Coronary Disease in 3 studies
Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This result was not significant but suggested a favorable effect of terazosin on diminishing the risk of coronary heart disease." | 9.09 | [Evaluation of serum lipid levels in clinical benign prostatic hyperplasia patients with terazosin monotherapy]. ( Kageyama, S; Tamaki, M; Ueda, T, 1999) |
| " This result was not significant but suggested a favorable effect of terazosin on diminishing the risk of coronary heart disease." | 5.09 | [Evaluation of serum lipid levels in clinical benign prostatic hyperplasia patients with terazosin monotherapy]. ( Kageyama, S; Tamaki, M; Ueda, T, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tamaki, M | 1 |
| Ueda, T | 1 |
| Kageyama, S | 1 |
| Grimm, RH | 1 |
| Rosenthal, J | 1 |
2 reviews available for terazosin and Coronary Disease
| Article | Year |
|---|---|
Antihypertensive therapy: taking lipids into consideration.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; | 1991 |
Blood pressure and lipid lowering effects of terazosin.
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Blood Pressure; Coronary Disease; Humans; Hyp | 1989 |
1 trial available for terazosin and Coronary Disease
| Article | Year |
|---|---|
[Evaluation of serum lipid levels in clinical benign prostatic hyperplasia patients with terazosin monotherapy].
Topics: Aged; Coronary Disease; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Prazosin; Prostatic Hype | 1999 |